Multivariable evaluation of maternal hemodynamic profile in pregnancy complicated by fetal growth restriction: prospective study.


Journal

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 04 05 2018
revised: 20 07 2018
accepted: 24 08 2018
pubmed: 13 9 2018
medline: 6 5 2020
entrez: 13 9 2018
Statut: ppublish

Résumé

To evaluate the association between fetal growth restriction (FGR) and maternal hemodynamic parameters using multivariable analysis, adjusting for major confounding factors, such as hypertensive disorders of pregnancy (pre-eclampsia and gestational hypertension). A prospective cohort study was conducted between January 2013 and April 2016. Two cohorts of patients were recruited, between 24 and 39 weeks of gestation, in a high-risk outpatient setting. These cohorts comprised 49 appropriate-for-gestational-age singleton fetuses and 93 that were FGR (abdominal circumference (AC) at recruitment in the second half of pregnancy ≤ 10 In the multivariable analysis, after adjustment for hypertensive disorders of pregnancy and smoking, FGR was associated with a 14% increase in maternal total vascular resistance, 16% reduction in cardiac output, 13% reduction in left ventricular mass and 11% reduction in heart rate; similar results were observed for the corresponding indexed parameters. Hypertensive disorders of pregnancy in the absence of FGR were associated with a 25% increase in total vascular resistance, 16% increase in left ventricular mass and 14% reduction in diastolic function; similar results were observed for the corresponding indexed parameters. FGR is significantly and independently associated with several maternal hemodynamic parameters, even after adjustment for major confounding factors, such as hypertensive disorders of pregnancy. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Identifiants

pubmed: 30207002
doi: 10.1002/uog.20118
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

732-739

Subventions

Organisme : Associazione Studio Malformazioni (ASM)

Informations de copyright

Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

Références

Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol 1989; 161: 1449-1453.
Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68: 540-543.
Poppas A, Shroff SG, Korcarz CE, Hibbard JU, Berger DS, Lindheimer MD, Lang RM. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation 1997; 95: 2407-2415.
Mesa A, Jessurun C, Hernandez A, Adam K, Brown D, Vaughn WK, Wilansky S. Left ventricular diastolic function in normal human pregnancy. Circulation 1999; 99: 511-517.
Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv 1994; 49: S1-14.
Duvekot JJ, Cheriex EC, Pieters FA, Peeters LL. Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy. Acta Obstet Gynecol Scand 1995; 74: 693-697.
Mahendru AA, Foo FL, Mceniery CM, Everett TR, Wilkinson IB, Lees CC. Change in maternal cardiac output from preconception to mid-pregnancy is associated with birth weight in healthy pregnancies. Ultrasound Obstet Gynecol 2017; 49: 78-84.
Vasapollo B, Valensise H, Novelli GP, Larciprete G, Di Pierro G, Altomare F, Casalino B, Galante A, Arduini D. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction. Ultrasound Obstet Gynecol 2002; 20: 452-457.
Vasapollo B, Valensise H, Novelli GP, Altomare F, Galante A, Arduini D. Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction. Ultrasound Obstet Gynecol 2004; 24: 23-29.
Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52: 873-880.
Bamfo JEAK, Kametas NA, Chambers JB, Nikolaides KH. Maternal cardiac function in normotensive and preeclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 32: 682-686.
Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction. Hypertension 2012; 60: 437-443.
Melchiorre K, Sutherland G, Sharma R, Nanni M, Thilaganathan B. Mid-gestational maternal cardiovascular profile in preterm and term pre-eclampsia: a prospective study. BJOG 2013; 120: 496-504.
Easterling TR, Benedetti TJ, Carlson KC, Brateng DA, Wilson J, Schmucker BS. The effect of maternal hemodynamics on fetal growth in hypertensive pregnancies. Am J Obstet Gynecol 1991; 165: 902-906.
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; SOGC Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 29: 416-438.
Robinson HP, Fleming JE. A critical evaluation of sonar “crown-rump length” measurements. BJOG 1975; 82: 702-710.
Snijders RJ, Nicolaides KH. Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994; 4: 34-48.
Nicolini U, Todros T, Ferrazzi E, Zorzoli A, Groli C, Zucca S, Tinti A, Dodero D, Destro F, Ceccarello P. Transverse fetal growth curves. A multicenter study. Minerva Ginecol 1986; 38: 873-887.
de Greeff A, Beg Z, Gangji Z, Dorney E, Shennan AH. Accuracy of inflationary versus deflationary oscillometry in pregnancy and preeclampsia: OMRON-MIT versus OMRON-M7. Blood Press Monit 2009; 14: 37-40.
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016; 29: 277-314.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1-39.
Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH. Maternal cardiac function at 35-37 week's gestation: relationship with birth weight. Ultrasound Obstet Gynecol 2017; 49: 67-72.
Prefumo F, Muiesan ML, Perini R, Paini A, Bonzi B, Lojacono A, Agabiti-Rosei E, Frusca T. Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 65-71.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH. Maternal cardiac function in fetal growth-restricted and non-growth-restricted small-for-gestational age pregnancies. Ultrasound Obstet Gynecol 2007; 29: 51-57.
De B Machado J, Filho PVM, O Petersen GO, Chatkin JM. Quantitative effects of tobacco smoking exposure on the maternal-fetal circulation. BMC Pregnancy Childbirth 2011; 11: 24.
Milnerowicz-Nabzdyk E, Bizon A. How does tobacco smoke influence the morphometry of the fetus and the umbilical cord? - Research on pregnant women with intrauterine growth restriction exposed to tobacco smoke. Reprod Toxicol 2015; 58: 79-84.
Jaaskelainen T, Suomalainen-Konig S, Hamalainen E, Pulkki K, Romppanen J, Heinonen S, Laivuori H; FINNPEC. Angiogenic profile and smoking in the Finnish Genetics of Preeclampsia Consortium (FINNPEC) cohort. Ann Med 2017; 24: 1-21.
Ahmed A. Molecular mechanisms and therapeutic implications of the carbon monoxide/hmox1 and the hydrogen sulfide/CSE pathways in the prevention of preeclampsia and fetal growth restriction. Pregnancy Hypertens 2014; 4: 243-244.
Guy GP, Zing HZ, Garcia P, Poon LC, Nicolaides KH. Maternal cardiovascular function at 35-37 weeks' gestation: relation to maternal characteristics. Ultrasound Obstet Gynecol 2017; 49: 39-45.

Auteurs

D D Di Martino (DD)

Department of Woman, Mother and Neonate, Buzzi Children's Hospital, University of Milan, Milan, Italy.

E Ferrazzi (E)

Department of Woman, Child and Neonate, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical and Community Health Sciences, University of Milan, Milan, Italy.

M Garbin (M)

Unit of Cardiology, Buzzi Children's Hospital, Milan, Italy.

F Fusè (F)

Department of Woman, Mother and Neonate, Buzzi Children's Hospital, University of Milan, Milan, Italy.

T Izzo (T)

Department of Woman, Mother and Neonate, Buzzi Children's Hospital, University of Milan, Milan, Italy.

J Duvekot (J)

Department of Obstetrics and Gynecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

A Farina (A)

Division of Obstetrics and Prenatal Medicine, Department of Medicine and Surgery (DIMEC) Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH